Geographic proximity and racial disparities in cancer clinical trial participation

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 12, 2010, Pages 1343-1351

  Kanarek, Norma F ^a,b   Tsai, Hua Ling ^b   Metzger Gaud, Sharon ^c   Damron, Dorothy ^b   Guseynova, Alla ^b   Klamerus, Justin F ^b   Rudin, Charles M ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Accruals to cases ratio; Accruals to cases ratio relative risk; Catchment area; Clinical trials; Disparities; Health services area; Poisson regression

Indexed keywords

ADULT; AGE; ARTICLE; CANCER CENTER; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; POVERTY; RACE; SEX; UNITED STATES;

EID: 78951485053     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0102     Document Type: Article

References (26)

1. Emmons KM, Burns White K, Benz EJ. Development of an integrated approach to cancer disparities: one cancer center's experience. Cancer Epidemiol Biomarkers Prev 2007;16:2186-2192.
2. Sloane D. Cancer epidemiology in the United States: racial, social, and economic factors. Methods Mol Biol 2009;471:65-83.
3. Betancourt JR. Eliminating racial and ethnic disparities in health care: what is the role of academic medicine? Acad Med 2006;81:788-792.
4. Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol 2006;24:2209-2215.
5. Bennett CL, Crane JM. Quality improvement efforts in oncology: are we ready to begin? Cancer Invest 2001;19:86-95.
6. The Cancer Centers Branch of the National Cancer Institute. Policies and Guidelines Relating to the Cancer Center Support Grant. September 2004. Available at: http://cancercenters.cancer. gov/documents/CCSG-Guide12-04.pdf. Accessed October 20, 2010.
7. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2006;3:e19.
8. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 2006;24:2170-2178.
9. Hyndman JC, D'Arcy C, Holman J, Pritchard DA. The influence of attractiveness factors and distance to general practice surgeries by level of social disadvantage and global access in Perth, Western Australia. Soc Sci Med 2003;56:387-403.
10. Basu J. An analysis of market shares of Maryland hospitals in their service areas. J Health Soc Policy 1994;6:71-85.
11. Su SC, Kanarek N, Fox MG, et al. Spatial analyses identify the geographic source of patients at an urban cancer center. Clin Cancer Res 2010;16:1065-1072.
12. Kay BJ. Describing health service areas: a methodological note on a summary indicator. Health Policy 1985;5:133-141.
13. Basu J. An analysis of hospital service areas, market shares, and access to care in Maryland. Baltimore, MD: Maryland Health Resources Planning Commission; March 1991.
14. Studnicki J. The minimization of travel effort as a delineating influence for urban hospital service areas. Int J Health Serv 1975;5:679-693.
15. American College of Surgeons (Commission on Cancer). Facility Oncology Registry Data Standards. 2007 Revision ed. Chicago, IL: ACOS; 2002.
16. Community Health Status Indicators (CHSI ) Project Team. CHSI Database. U.S. Department of Health and Human Services. Washington, DC: Health Resources and Services Administration; 2008.
17. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc 2007;99:1092-1100, 1102-1104.
18. Belsey DA, Kuh E, Welsch RE. Regression diagnostics: identifying influential data and sources of collinearity. Hoboken, NJ: Wiley-Interscience; 1980.
19. Armstrong K, Hughes-Halbert C, Asch DA. Patient preferences can be misleading as explanations for racial disparities in health care. Arch Intern Med 2006;166:950-954.
20. Baquet CR, Ellison GL, Mishra SI. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials. J Clin Oncol 2008;26:3380-3886.
21. Dranove D, White WD, Wu L. Segmentation in local hospital markets. Med Care 1993;31:52-64.
22. Probst JC, Laditka SB, Wang JY, Johnson AO. Effects of residence and race on burden of travel for care: cross sectional analysis of the 2001 US National Household Travel Survey. BMC Health Serv Res 2007;7:40.
23. Basu J, Friedman B. A re-examination of distance as a proxy for severity of illness and the implications for differences in utilization by race/ethnicity. Health Econ 2007;16:687-701.
24. Goss E, Lopez AM, Brown CL, et al. American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol 2009;27:2881-2885.
25. Ness RB, Nelson DB, Kumanyika SK, Grisso JA. Evaluating minority recruitment into clinical studies: how good are the data? Ann Epidemiol 1997;7:472-478.
26. McKoy JM, Samaras AT, Bennett CL. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol 2009;27:2745-2746.